WallStreetZenWallStreetZen

NASDAQ: RGLS
Regulus Therapeutics Inc Stock Ownership - Who owns Regulus Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Regulus Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joseph P. HaganChief Executive Officer2025-01-3050,000$1.09
$54.25kBuy
David BaltimoreDirector2025-01-3019,610$1.06
$20.79kBuy
Crispina CalsadaChief Financial Officer2025-01-145,088$1.26
$6.43kSell
Joseph P. HaganChief Executive Officer2025-01-1411,764$1.26
$14.86kSell
Christopher Ray AkerSr. VP General Counsel2025-01-145,088$1.26
$6.43kSell
Christopher Ray AkerSr. VP General Counsel2025-01-1338,547$1.26
$48.68kSell
Preston KlassenPresident Head of R D2025-01-1331,445$1.26
$39.72kSell
Joseph P. HaganChief Executive Officer2025-01-13115,290$1.26
$145.61kSell
Crispina CalsadaChief Financial Officer2025-01-1338,716$1.26
$48.90kSell
Christopher Ray AkerSr. VP General Counsel2025-01-0966,625$1.36
$90.61kBuy

1 of 2

RGLS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGLS insiders and whales buy or sell their stock.

RGLS Shareholders

What type of owners hold Regulus Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc19.40%12,852,654$25.83MInstitution
Ravi Viswanathan16.59%10,989,010$22.09MInsider
Chetan Puttagunta16.59%10,989,010$22.09MInsider
Jon Sakoda16.59%10,989,010$22.09MInsider
Joshua Makower12.84%8,503,510$17.09MInsider
Paul Edward Walker12.84%8,503,510$17.09MInsider
Peter W. Sonsini12.84%8,503,510$17.09MInsider
Mohamad Makhzoumi12.84%8,503,510$17.09MInsider
Anthony A. Florence Jr.12.84%8,503,510$17.09MInsider
Carmen Chang12.84%8,503,510$17.09MInsider

1 of 3

RGLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGLS23.05%76.95%Net BuyingNet Buying
KRRO25.11%74.89%Net Buying
NBTX12.79%0.00%
LRMR53.68%46.32%
ACIU27.26%0.00%
View Top Biotech Stocks

Regulus Therapeutics Stock Ownership FAQ

Who owns Regulus Therapeutics?

Regulus Therapeutics (NASDAQ: RGLS) is owned by 80.78% institutional shareholders, 269.62% Regulus Therapeutics insiders, and 0.00% retail investors. Ravi Viswanathan is the largest individual Regulus Therapeutics shareholder, owning 10.99M shares representing 16.59% of the company. Ravi Viswanathan's Regulus Therapeutics shares are currently valued at $25.49M.

If you're new to stock investing, here's how to buy Regulus Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.